News | Sudden Cardiac Arrest | July 26, 2019

Cardiac Arrest Among Hospitalized Patients May Be Underestimated

The health burden of in-hospital adult cardiac arrest is about 38 percent greater than earlier reports and 18 percent greater for children, according to one study

Cardiac Arrest Among Hospitalized Patients May Be Underestimated

July 26, 2019 — Significantly more patients suffer cardiac arrests in U.S. hospitals each year than previously estimated, according to new research in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

Cardiac arrest, which occurs when the heart malfunctions and stops beating, is not the same as a heart attack, which occurs when blood flow to the heart is blocked.

Researchers developed a model for estimating cardiac arrest incidence using data on facilities from the American Hospital Association annual survey, which included hospitals linked to the American Heart Association’s Get With The Guidelines-Resuscitation (GWTG-R) registry. In 2011 when cardiac arrest data from the two registries was last analyzed, annual incidence was estimated to be 211,000 for adults and 6,000 in children.

The new study estimates that there are about 292,000 adult in-hospital cardiac arrests and 15,200 pediatric in-hospital events (of which 7,100 cases were pulseless cardiac arrests and 8,100 cases in which there was a pulse but still requiring CPR) in the United States each year. Compared to previous reports, the public health burden of adult and pediatric pulseless in-hospital cardiac arrest is approximately 38 percent and 18 percent greater than previously estimated.

“Our findings illustrate a concerning trend in U.S. hospitals, and show that cardiac arrest is a major public health problem,” said Lars W. Andersen, M.D., MPH, Ph.D., DMSc., study co-author and associate professor at Aarhus University in Denmark, who oversaw the study as a visiting researcher at Beth Israel Deaconess Medical Center’s Department of Emergency Medicine in Boston. “Previous incidence estimates may no longer reflect the current public health burden of cardiac arrest in hospitalized patients across the U.S. Unfortunately, the data does not provide an explanation for the increase in adult in-hospital cardiac arrest, but it is likely due to many factors and may reflect an increase in actual events or in the reporting of cases over time.”

Andersen said the findings may suggest that basic life support and advanced cardiac life support training programs — which traditionally have focused on out-of-hospital resuscitation — may need to be expanded to include potential in-hospital responders.

Researchers found no indication that the number of pediatric events has increased over time. Instead, the current estimates are based on a larger database and provide the most robust estimate of pediatric in-hospital cardiac arrest cases in the United States to date.

In 2015, prevention of in-hospital cardiac arrest was added to the Chain of Survival in the American Heart Association’s Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Although preventing cardiac arrest is complex, possible steps to reduce in-hospital cases include educating more medical personnel, identifying deteriorating patients through early warning signs, and early intervention by rapid response and emergency response teams.

“It is also important to note that end-of-life discussions and decisions are crucial in order to avoid attempts at resuscitation in patients where it is likely futile or against a patient’s wishes,” Andersen said.

He also noted that the findings should be interpreted with caution as data was limited to data from GWTG-R hospitals.

Co-authors are Mathias Johan Holmberg, M.D., MPH; Catherine Ross, M.D.; Garrett Fitzmaurice, Sc.D.; Paul Chan, M.D.; Jordan Duval-Arnould, Ph.D.; Anne Grossestreuer, Ph.D.; and Michael Donnino, M.D. Author disclosures are on the manuscript.

There was no specific funding for the study.

For more information: www.ahajournals.org/journal/circoutcomes

 

Reference

1. Holmberg M.J., Ross C.E., Fitzmaurice G.M., et al. Annual Incidence of Adult and Pediatric In-Hospital Cardiac Arrest in the United States. Circulation: Cardiovascular Quality and Outcomes, published online July 9, 2019. https://doi.org/10.1161/CIRCOUTCOMES.119.005580

Related Content

FDA Issues Final Guidance on Live Case Presentations During IDE Clinical Trials
News | Cardiovascular Clinical Studies | July 10, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance “Live Case Presentations During Investigational...
Veradigm Partners With American College of Cardiology on Next-generation Research Registries
News | Cardiovascular Clinical Studies | July 03, 2019
The American College of Cardiology (ACC) has partnered with Veradigm, an Allscripts business unit, to power the next...
New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
Overlay Init